STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more

(MedPage Today) -- CHICAGO -- An oral targeted drug reduced the risk of disease progression or death by 35% compared with chemotherapy when given as first-line treatment for non-small cell lung cancer (NSCLC) patients with EGFR exon 20 insertions...

You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here.   We’re ASCOmaxxing. Rest…

(MedPage Today) -- Researchers unveiled a new multimodal artificial intelligence (AI) algorithm for cardiac amyloidosis (CA) diagnosis, a tool showing promise for greater accuracy and sensitivity in the real world. The AI echo-clinical model ...

(MedPage Today) -- Enhanced, abbreviated MRI (AMRI) outperformed ultrasonography (US) as a screen for early liver cancer in high-risk patients with cirrhosis, according to a single-center, randomized clinical trial. Overall, AMRI yielded significantly...